Keeping tabs on Covid-19: BioNTech buys GMP-certified facility to boost vaccine…
The Pharma Data
SEPTEMBER 18, 2020
BioNTech acquires Novartis GMP manufacturing site to expand Covid-19 vaccine production. BioNTech has agreed to buy a Novartis manufacturing facility in Marbury, Germany, to expand its Covid-19 vaccine production capacity by up to 750 million doses per year, or more than 60 million doses per month, once fully operational.
52 
Let's personalize your content